← Back to headlines
JPMorgan Raises Price Target on Xenon Pharmaceuticals (XENE)
JPMorgan has adjusted its price target upwards for Xenon Pharmaceuticals (XENE), reflecting a potentially more optimistic view on the company's future performance.
23 May, 02:31 — 23 May, 02:31
Sources
Showing 1 of 1 sources
